Wednesday, 15 April 2026
PERSPECTA
News from every angle
All
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
Johnson & Johnson (JNJ) Targets Opportunities around Multiple Myeloma with TECVAYLI
16 Mar, 21:10 — 16 Mar, 21:10
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
Yahoo
Mostly Factual
29d ago
Johnson & Johnson (JNJ) Targets Opportunities around Multiple Myeloma with TECVAYLI
Read full article →
Something wrong with this story? Report an issue
Related Stories
Toxic Smoke from Navotas Landfill Fire Reaches Bulacan Villages
just now
Financial Barriers Hinder Vaccine Access in Philippines
just now
Man Injects Unapproved Peptides for Fitness, Risks Health
20m ago
Rio de Janeiro Implements Policy to Combat Childhood Obesity in Schools
45m ago
Wednesday, 15 April 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
